Colorado piloted a multi-payer patient-centered medical home model and a recent analysis sponsored by the Commonwealth Fund looked at results from he first three years of the pilot. (Commonwealth Summary) The pilot involved 15 practices and covered about 100,000 patients. The three-year evaluation was considered important because of a belief that it takes a while for practices to fully adopt the medical home model and for its benefits to be reflected. Over this period there were some important gains. Emergency room use went down by about 9.3%, or 1.6 visits per thousand member months. This was up slightly from the end of the second year, indicating sustained and continuing improvement. The cost implications of less ER use amounted to $3.50 per member per month. For patients with two or more illnesses, there was a 10% reduction in avoidable hospitalizations. Somewhat surprisingly, there was a reduction in primary care visits or 4.2 per thousand member months. Nothwithstanding the lower costs in some areas, overall spending on these patients was not reduced, indicating increases elsewhere, and I suspect that if the full costs to the physician practices has been included, there was a net spending increase. I suspect this analysis is complicated by the continued growth in high-deductible plans. Be useful to see a sub-analysis by benefit design. Among quality measures there were mixed outcomes. There was 3.3% increase in cervical cancer screenings, but a lower rate of colon cancer screening and of testing for blood sugar control in diabetes patients. All-in-all, seems like a pretty negative outcome for this pilot, with very minor quality improvements and a net increase in health costs.
Results From Another Medical Home Initiative
By Kevin RocheNovember 3, 2015Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…
March 24, 2023
A Couple of Health Care Notes
A couple of pieces of health care research focus on high health care spending and…